Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xylem Inc.XYL · Entity 430 | EVP & Pres, AW | March 05, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xylem Inc.
Report date March 05, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,447 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Tax withholding · Disposed 158 · Balance 5,447 F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (158) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (158) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 6, 2026 16:19 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 158 | $126.19 | $19,938.02 |
DisclosureSEC source: 0001524472-26-000055 · form4.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · EVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,447 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (158) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:59 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,739 | $128.98 Strike: $128.98 | $740,216.22 |
DisclosureSEC source: 0001524472-26-000039 · form4.xml · derivative · entry 2 Emmerich Meredith · CIK 0002040538 · EVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,739 Underlying: Common Stock · 5,739 shares Expires 2036-03-02 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:59 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000039 · form4.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · EVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,605 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| October 21, 2025 Filed Oct 21, 2025 17:02 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 841 | $147.19 | $123,786.79 |
DisclosureSEC source: 0002040538-25-000002 · primarydocument.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · EVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,992 F1 · shares: Reflects the withholding of 841 shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on October 21, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 16:11 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Options (Right to buy) · Derivative | 3,721 | $129.67 Strike: $129.67 | $482,502.07 |
DisclosureSEC source: 0001562180-25-002144 · primarydocument.xml · derivative · entry 2 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,721 Underlying: Common Stock · 3,721 shares Expires 2035-03-05 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 16:11 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,060 | $129.67 | $137,450.20 |
DisclosureSEC source: 0001562180-25-002144 · primarydocument.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,833 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| October 21, 2024 Filed Oct 23, 2024 16:15 UTC | Xylem Inc. XYL · Entity 430 | GrantStock Options (Right to buy) · Derivative | 33,138 | $132.54 Strike: $132.54 | $4,392,110.52 |
DisclosureSEC source: 0001562180-24-007435 · primarydocument.xml · derivative · entry 2 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 Underlying: Common Stock · 33,138 shares Expires 2034-10-21 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on October 21, 2025, October 21, 2026 and October 21, 2027. Read SEC document |
| October 21, 2024 Filed Oct 23, 2024 16:15 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,772 | $132.54 | $499,940.88 |
DisclosureSEC source: 0001562180-24-007435 · primarydocument.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-half increments on October 21, 2025 and October 21, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.